cGxP.wire https://validator.w3.org/feed/docs/rss2.html Verastem Oncology Shows Encouraging Survival Data in RAMP 205 Pancreatic Cancer Trial F2G and Shionogi Report Positive Phase 3 OASIS Results D&D Pharmatech Phase 2 MASH Data Shows Strong Fibrosis Gains VahatiCor Enrolls First U.S. Patient in A-FLUX SERRA-I Trial Acurx Pharmaceuticals Showcases DNA pol IIIC Antibiotic Breakthrough Roche Secures FDA sBLA Acceptance for Lunsumio VELO Combination CTAD and ADDF Unite to Accelerate Alzheimer’s Innovation Verastem Oncology Doses First Patient in TARGET-D 201 Trial Vedana Therapeutics Raises $46 Million to Advance Migraine Therapies NMD Pharma Reports Positive Phase 2a Ignaseclant Data in CMT UCB Reports Positive KYGEVVI Outcomes in TK2d Patients Skin Tech Pharma Group Wins Best Injectable at AMWC 2026 Resolution Therapeutics Expands Regenerative Macrophage Therapy with In Vivo Platform Bristol Myers Squibb Declares Quarterly Dividend Payment Assertio Finalizes Merger with Zydus Lifesciences and Delists from Nasdaq Triveni Bio Secures $65M to Advance TRIV-573 Development FiberSense CGM System Achieves CE Mark for Market Launch Protillion Biosciences Partners With Merck on AI Drug Discovery Simulations Plus to Join Altaris in $375M Acquisition Deal Jazz Presents New Xywav Data at SLEEP 2026 Meeting Jazz and AbCellera Partner on Next-Gen Cancer Antibodies Dimerix Licenses DMX-200 to Everest Medicines in Asia Zai Lab Secures EMA Support for Rare Lung Cancer Therapy AccurKardia’s AK-AVS Joins FDA TAP Program for AI Heart Screening Niowave and Ratio Partner to Advance Actinium-225 Supply Innoviva and Dr. Reddy’s Expand Global Access to XACDURO® Intelligent Bio Solutions Expands Clinical Validation of Fingerprint Drug Screening Technology FibroBiologics Doses First Patients in Phase 1/2 Trial of CYWC628 for Diabetic Foot Ulcers Quoin Advances QRX003 Development with Positive Pediatric Netherton Syndrome Update Akston’s AKS-699 Demonstrates One-Year Pruritus Control with Fewer Treatments Nexalin Technology Highlights Positive Anxiety and Insomnia Data at NYC Neuromodulation Conference 2026 SonoClear Study Selected for EANS 2026 Oral Presentation NeOnc Expands International Clinical Development of NEO212 for Glioblastoma Nervonik Completes First Human Nerve Sensing Study Edgewise Reports Positive Phase 2 EDG-7500 HCM Data Guided Therapeutics Advances FDA Review of LuViva Cervical Cancer Screening Technology Castle TissueCypher Surpasses 100,000 Orders in Barrett’s Optimi Health Launches Standardized Psilocybin Microdose Capsules for Clinical Research Fujifilm and HORIBA Achieve 10% Antibody Yield Improvement with New Raman Technology FDA Approves Allergan’s SKINVIVE by JUVÉDERM for Neck Line Reduction Takeda Oveporexton Shows Broad Benefits in Narcolepsy SurGenTec Gains FDA Clearance for ION-L Spine System Gilead’s Once-Weekly Yeztugo Accepted by FDA for HIV Prevention Review Qihan Biotech’s QT-019B Earns FDA RMAT and Breakthrough Therapy Designations Alkermes Highlights Strong Phase 2 Data for Alixorexton at SLEEP 2026 Halia Therapeutics Secures FDA Fast Track for Ofirnoflast BioMarin Reports Positive VOXZOGO and BMN 333 Data at ENDO 2026 AMDI Wins FDA Approval for Sub-10-Minute Respiratory PCR Test Halozyme Reaffirms Long-Term Royalty Growth Despite Proposed Medicare Pricing Changes Corcept Resubmits Relacorilant NDA for Cushing’s Syndrome to FDA